Frequency of unexpected antibody and consideration during transfusion

Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, College of Medicine, Inje University, Seoul, Korea.
Korean journal of anesthesiology 05/2012; 62(5):412-7. DOI: 10.4097/kjae.2012.62.5.412
Source: PubMed


In this retrospective study, we measured the frequency of unexpected antibodies in the blood. Specific considerations for preoperative preparations were kept in mind for the patients undergoing surgery positive for these antibodies.
After reviewing the results of antibody screening tests lasted for 2 years, the frequency of unexpected antibodies was determined. Surgical patients who were positive for unexpected antibodies were selected and divided into two groups based on their potential need for an intra-operative transfusion (groups with high versus low possibility of transfusion). Blood for the high possibility group was prepared before surgery. For the low possibility group for which preoperative blood preparation was not performed, cases of this group were reviewed whether a blood preparation was delayed or not in case of transfusion.
Among a total 22,463 cases, 340 (1.52%) had positive results for antibody screening tests. Among the 243 patients who were positive for unexpected antibodies, Lewis, Rh, Xga, and mixed antibodies were found in 85, 25, five, and eight cases, respectively. Out of 243 patients, 117 patients, specificities of the unexpected antibodies were not determined and 125 (51.4%) had a history of pregnancy and delivery, and 49 (20.2%) had a history of transfusion. In the low probability group, transfusions were administered for nine patients; transfusion was delayed for two patients due to difficulties with obtaining matched blood.
Patients with unexpected blood antibodies may be at increased risk for delayed transfusion. For rapid transfusion, it might be helpful to keep a record about blood antibodies and introduce a notification system such as medical alert cards. Preoperative blood preparation is needed for timely intraoperative transfusion.

Download full-text


Available from: Kye-Min Kim, Nov 21, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: But de l’étude La recherche des agglutinines irrégulières est un examen pré-transfusionnel obligatoire et fondamental pour la prévention des accidents immuno-hémolytiques de la transfusion sanguine. Les deux principales techniques utilisées sont le Coombs indirect (CI) et la technique enzymatique. Cette dernière tend à être abandonnée, en raison du nombre élevé de faux positifs. Le but de ce travail est d’évaluer, à l’aide de ces deux techniques, l’allo-immunisation anti-érythrocytaire chez des patients marocains candidats à une transfusion sanguine. Patients et méthodes Cette étude prospective a été menée sur une période de deux mois et demi. L’échantillon comprenait 2027 sérums de patients candidats à une transfusion. Un dépistage des agglutinines irrégulières a été systématiquement effectué chez tous les patients, suivi d’une identification des anticorps de tous les sérums positifs. Le dépistage et l’identification ont été effectués en technique de CI et en enzyme selon un procédé de filtration sur colonne (Ortho-Biovue). Résultats Le dépistage des anticorps anti-érythrocytaires est positif chez 196 patients (9,6 %). L’identification montre une positivité dans 3,1 % des cas en technique de CI, 60,7 % en test enzymatique et 36,2 % dans les deux techniques. Les anticorps dirigés contre les antigènes du système rhésus constituent 60,4 % de l’ensemble des anticorps mis en évidence. Conclusion Notre étude montre l’existence d’un risque immunologique chez les patients candidats à une transfusion. La pratique de la recherche des agglutinines irrégulières en technique enzymatique reste justifiée chez les patients qui ne bénéficient pas d’une transfusion iso-rhésus de façon systématique.
    No preview · Article · Aug 2013 · Immuno-analyse & Biologie Spécialisée
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background & objectives: The development of alloantibodies can significantly complicate transfusion therapy and results in difficulties in cross-matching of blood. Most literature on alloimmunization is limited to multitransfused individuals, with very few studies on the general hospital patients. This study was aimed at assessing the frequency and type of unexpected red cell antibodies in the general patient population at a multispecialty tertiary care centre in New Delhi, India. Methods: The results of 49,077 antibody screening tests carried out on patients, from January 2009 to December 2012 were analyzed. The clinical and transfusion records were reviewed. The data were compiled and statistically analysed. Results: A total of 49,077 (29,917; 60.96% males and 19,160; 39.04% females) patient samples were screened for the presence of unexpected antibodies. Antibody screening was positive in 403 patients (0.82%). In the serum samples of 164 patients only autoantibodies were identified, 27 revealed autoantibodies with one or more underlying alloantibodies, while 212 patients had only alloantibody/ies in their serum. The overall alloimmunization rate was 0.49 per cent. Antibodies against the Rh system were the most frequent (64.1%), the most common alloantibody identified being anti E (37.2%), followed by anti D (19.2%). Interpretation & conclusions: Since clinically significant antibodies are frequently detected in our patient population, antibody screening and if required, identification is the need of the hour. Since antibodies against the common Rh and Kell blood group antigens are the most frequent, provision of Rh and Kell matched red cells may be of protective value.
    No preview · Article · Sep 2014 · The Indian Journal of Medical Research

  • No preview · Article · Oct 2014 · Blood transfusion = Trasfusione del sangue